Nykode Therapeutics ASA — Share Issue/Capital Change 2021

Jun 29, 2021

Share capital increase from exercise of warrants

Share capital increase from exercise of warrants

As a consequence of exercise of 400,000 warrants in Vaccibody AS, the share capital of Vaccibody AS has increased by NOK 4,000.00 from NOK 2,861,438.45 to NOK 2,865,438.45. The number of outstanding shares in the company has increased by 400,000 from 286,143,845 to 286,543,845, each with a par value of NOK 0.01. The warrants were exercised by a former board member at a strike price of NOK 2.50 per share.